About This Course

HIV-associated tuberculosis remains the major cause of death among HIV-infected individuals. New knowledge on effective prevention, early diagnosis and treatment of drug-susceptible TB and drug-resistant TB in HIV-infected individuals has been acquired. The most important latest developments and new recommendations being relevant for your daily practice will be discussed. Moreover, it includes an overview of symptoms and signs of pulmonary and extrapulmonary TB and practical guidance for co-management TB and HIV in daily practice . This course replaces the previous courses on HIV-associated tuberculosis.

This 3 weeks course was prepared in cooperation with Dr. Adele Schwartz Benzaken, Senior Global Medical Director and Dr. Fernanda Fonseca, Associate Global Medical Director, and will be awarded with 4.0 AHF CME credit hours.